Love Hemp Group Intends To Investigate Comments Made By Philip Small

Jan 23 (Reuters) - Marksans Pharma Ltd: * MARKSANS PHARMA LTD - ANNOUNCES UK MHRA APPROVAL FOR FLUOXETINE 20MG/5ML ORAL SOLUTION * MARKSANS PHARMA LTD - PRODUCT WILL BE MANUFACTURED AT PLANT OF BELL,

Jan 23 (Reuters) - Surgical Innovations Group PLC : * YEAR-END TRADING UPDATE * SIGNIFICANT IMPROVEMENT IN SALES, AHEAD OF MARKET EXPECTATIONS AND A RETURN TO PROFITABILITY IN H2 * REVENUES FOR YEAR

Jan 23 (Reuters) - Primary Health Properties PLC : * ACQUISITION * ACQUIRED AXIS TECHNICAL SERVICES LIMITED Source text for Eikon: Further company coverage:

* Myovant Sciences Ltd is expected to show a rise in quarterly revenue when it reports results on January 24 (estimated). * The London United Kingdom-based company is expected to report a 88.0%

20 January 2023 02:36 p.m. All figures in US dollars. Myovant Sciences Ltd is expected to show an increase in its fourth quarter earnings to -47 cents​ per share according to the mean Refinitiv

Jan 20 (Reuters) - Aptorum Group Ltd: * APTORUM GROUP ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT * APTORUM GROUP LTD - ANNOUNCED 1-FOR-10 REVERSE STOCK SPLIT OF CO'S CLASS A ORDINARY SHARES * APTORUM

Jan 20 (Reuters) - EMIS Group PLC: * EMIS GROUP PLC - YEAR END TRADING UPDATE AND ACQUISITION TIMETABLE * EMIS GROUP PLC - 2022 REVENUE AND ADJUSTED OPERATING PROFIT IN LINE WITH BOARD'S EXPECTATIONS

Jan 20 (Reuters) - Allergy Therapeutics PLC: * ALLERGY THERAPEUTICS - HALF-YEAR TRADING UPDATE 2023 * ALLERGY THERAPEUTICS PLC- GROUP EXPECTS REVENUE FOR SIX MONTHS ENDED 31 DECEMBER 2022 TO BE £39.9M

Jan 20 (Reuters) - CMA: * CMA: START OF CMA MERGER INVESTIGATION: ANTICIPATED ACQUISITION BY UNITEDHEALTH GROUP INCORPORATED OF EMIS GROUP PLC

Jan 20 (Reuters) - Love Hemp Group PLC: * LOVE HEMP GROUP PLC - DIRECTORATE CHANGE * LOVE HEMP GROUP PLC - APPOINTMENT OF FAHMEEDA KHAN, AS INTERIM FINANCIAL DIRECTOR AND BOARD DIRECTOR, WITH